Mylan names head of OTC division
HERTFORDSHIRE, England - Mylan on Friday announced the appointment of Ranjan Ray Chaudhuri to serve as global commercial lead of the company's over-the-counter business. Chaudhuri will report to Rajiv Malik, president of Mylan.
"As we have previously stated, we are committed to investing significantly to expand our OTC business, knowing that OTC is an important channel that will complement our existing strengths in the prescription and generic channels around the world," stated Heather Bresch, Mylan CEO. "This is why we believe our combination with the Perrigo and Omega platforms presents such a compelling opportunity to accelerate our efforts."
"Ranjan joins us at an opportune time, bringing deep knowledge of the OTC space, sales and marketing leadership, experience in developed and emerging markets, and a proven track record for delivering results," Malik added. "He will work closely with me and my colleagues at the global level, as well as others, within both Mylan's and Perrigo's commercial structures, to further realize the combination's commercial value should we complete the Perrigo transaction."
Chaudhuri joins Mylan from GlaxoSmithKline Consumer Healthcare, where he served for nearly three decades. During his time at GSK, Chaudhuri was responsible for the company's global smoking reduction and cessation category, which included NiQuitin and other nicotine replacement therapies. In addition, Chaudhuri led the development of a program designed to improve the quality of life of COPD patients by leveraging NRTs along with other GSK respiratory products, such as Advair and Seretide.
Prior to that, Chaudhuri served as innovation director for GSK's smoking control and cold sore franchises.
Chaudhuri recently led the divestiture of an OTC portfolio of NRT products to Perrigo, a move prompted by GSK's formation of a consumer healthcare joint venture with Novartis.
Earlier in his career with GSK Consumer Healthcare, Chaudhuri served in a variety of capacities, including global head of eMarketing, a function he launched; head of strategic planning for North America; and global director, analgesics category management, during which time he drove the growth of Panadol, GSK's leading analgesic brand, in multiple regions.
In addition, he served in various sales and marketing leadership positions, and helped grow the revenue and share of products such as Panadol, nutritional drinks Horlicks and Boost and hair-styling agent Brylcreem. Chaudhuri started his career at Unilever, selling Lipton tea in India.
Chaudhuri received a Bachelor of Arts (Honors) from St. Xavier's College in Calcutta, India, and a postgraduate diploma in business management from Institute of Modern Management, Calcutta, India.